Emergent BioSolutions Inc. (EBS)
Pharmaceutical Preparations
Latest Price
$6.36
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
6.60
P/B Ratio
0.96
Valuation metrics
adjust assumptions →EPS: $0.93
Book value / share: $10.03
Formula: √(22.5 × EPS × BVPS)
Graham Number
$14.49
+128% upside
Norm. op. income: $100M (median of 7yr)
Tax rate: 28%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$6.44
+1% upside
Base FCF: $96M (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$129.90
+1942% upside
EPS: $0.93
Target P/E: 15×
Formula: EPS × P/E
P/E Fair Value
$13.95
+119% upside
Institutional Ownership
82.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4.72M | $39.0M | 9.19% | +375.1K | 2026-06-30 |
| DIMENSIONAL FUND ADVISORS LP | 3.08M | $25.0M | 6.00% | +319.5K | 2026-06-30 |
| STATE STREET CORP | 2.93M | $24.0M | 5.71% | +79.5K | 2026-06-30 |
| AMERICAN CENTURY COMPANIES INC | 2.77M | $23.0M | 5.40% | +344.7K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.20M | $18.0M | 4.29% | -59.2K | 2026-06-30 |
| LSV ASSET MANAGEMENT | 1.70M | $14.0M | 3.31% | +799.2K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.34M | $11.0M | 2.61% | +64.3K | 2026-06-30 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.20M | $10.0M | 2.34% | -305.3K | 2026-06-30 |
| Sixth Street Partners Management Company, L.P. | 1.20M | $10.0M | 2.34% | -- | 2026-06-30 |
| OAK HILL ADVISORS LP | 1.11M | $9.0M | 2.17% | -- | 2026-06-30 |